Pancreatic serous cystadenoma

Pancreatic serous cystadenoma is a benign tumour of pancreas. It is usually found in the tail of the pancreas,[2] and may be associated with von Hippel-Lindau syndrome.[3]

Pancreatic serous cystadenoma
Other namesSerous cystadenoma of the pancreas, serous microcystic adenoma
Micrograph showing a pancreatic serous cystadenoma. H&E stain.
SpecialtyGeneral surgery, gastroenterology
SymptomsUsually asymptomatic
Usual onset50-60 years of age
Risk factorsFemale gender
TreatmentSurgical resection (if symptomatic)
Deaths0.1%[1]

In contrast to some of the other cyst-forming tumors of the pancreas (such as the intraductal papillary mucinous neoplasm and the mucinous cystic neoplasm), serous cystic neoplasms are almost always entirely benign. There are some exceptions; rare case reports have described isolated malignant serous cystadenocarcinomas.[4] In addition, serous cystic neoplasms slowly grow, and if they grow large enough they can press on adjacent organs and cause symptoms.

Signs and symptoms

In most cases, serous cystadenomas of the pancreas are asymptomatic.[5] However, large cysts may cause symptoms related to their size.[5]

Classification

Pathologists classify serous cystic neoplasms into two broad groups. Those that are benign, that have not spread to other organs, are designated "serous cystadenoma".[6] Serous cystadenomas can be further sub-typed into microcystic, oligocystic (or macrocystic), solid, mixed serous-endocrine neoplasm, and VHL-associated serous cystic neoplasm. This latter classification scheme is useful because it highlights the range of appearances and the clinical associations of these neoplasms. Serous cystic neoplasms that have spread ("metastasized") to another organ are considered malignant and are designated "serous cystadenocarcinoma".

Pathology

Treatment

These lesions rarely require surgery unless they are symptomatic or the diagnosis is in question. Since these lesions do not have malignant potential, long-term observation with imaging surveillance is unnecessary.[5] Surgery can include the removal of the head of the pancreas (a pancreaticoduodenectomy), removal of the body and tail of the pancreas (a distal pancreatectomy), or rarely removal of the entire pancreas (a total pancreatectomy).[7] In selected cases the surgery can be performed using minimally invasive techniques such as laparoscopy.[8]

Epidemiology

Serous cystadenomas of the pancreas are more common in women.[5] SCAs are usually diagnosed in people 50-60 years of age.[5]

See also

References

  1. Jais, B; Rebours, V; Malleo, G; Salvia, R; Fontana, M; Maggino, L; Bassi, C; Manfredi, R; Moran, R; Lennon, AM; Zaheer, A; Wolfgang, C; Hruban, R; Marchegiani, G; Fernández Del Castillo, C; Brugge, W; Ha, Y; Kim, MH; Oh, D; Hirai, I; Kimura, W; Jang, JY; Kim, SW; Jung, W; Kang, H; Song, SY; Kang, CM; Lee, WJ; Crippa, S; Falconi, M; Gomatos, I; Neoptolemos, J; Milanetto, AC; Sperti, C; Ricci, C; Casadei, R; Bissolati, M; Balzano, G; Frigerio, I; Girelli, R; Delhaye, M; Bernier, B; Wang, H; Jang, KT; Song, DH; Huggett, MT; Oppong, KW; Pererva, L; Kopchak, KV; Del Chiaro, M; Segersvard, R; Lee, LS; Conwell, D; Osvaldt, A; Campos, V; Aguero Garcete, G; Napoleon, B; Matsumoto, I; Shinzeki, M; Bolado, F; Fernandez, JM; Keane, MG; Pereira, SP; Acuna, IA; Vaquero, EC; Angiolini, MR; Zerbi, A; Tang, J; Leong, RW; Faccinetto, A; Morana, G; Petrone, MC; Arcidiacono, PG; Moon, JH; Choi, HJ; Gill, RS; Pavey, D; Ouaïssi, M; Sastre, B; Spandre, M; De Angelis, CG; Rios-Vives, MA; Concepcion-Martin, M; Ikeura, T; Okazaki, K; Frulloni, L; Messina, O; Lévy, P (February 2016). "Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas)". Gut. 65 (2): 305–12. doi:10.1136/gutjnl-2015-309638. hdl:11577/3187425. PMID 26045140.
  2. Colonna, J.; Plaza, JA.; Frankel, WL.; Yearsley, M.; Bloomston, M.; Marsh, WL. (2008). "Serous cystadenoma of the pancreas: clinical and pathological features in 33 patients". Pancreatology. 8 (2): 135–41. doi:10.1159/000123606. PMID 18382099. S2CID 28918883.
  3. Eras, M.; Yenigun, M.; Acar, C.; Kumbasar, B.; Sar, F.; Bilge, T. (2004). "Pancreatic involvement in Von Hippel-Lindau disease". Indian J Cancer. 41 (4): 159–61. PMID 15659868.
  4. Galanis C, Zamani A, Cameron JL, et al. (July 2007). "Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment". J. Gastrointest. Surg. 11 (7): 820–6. doi:10.1007/s11605-007-0157-4. PMID 17440789. S2CID 32023143.
  5. Elta, GH; Enestvedt, BK; Sauer, BG; Lennon, AM (April 2018). "ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts". The American Journal of Gastroenterology. 113 (4): 464–479. doi:10.1038/ajg.2018.14. PMID 29485131. S2CID 3584079.
  6. "Pathology of Neoplasms of the Pancreas". Johns Hopkins University. Retrieved 25 April 2010.
  7. "Pancreatic Surgery". Johns Hopkins University. Retrieved 25 April 2010.
  8. "Laproscopic Pancreatic Surgery". Johns Hopkins University. Retrieved 25 April 2010.
Classification
External resources
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.